Indications for: SUPPRELIN LA
Central precocious puberty.
<2yrs: not recommended. ≥2yrs: Insert 1 implant SC in the inner aspect of the upper arm. Remove after 12 months; may replace. Consider discontinuing at appropriate time point for onset of puberty.
SUPPRELIN LA Contraindications:
SUPPRELIN LA Warnings/Precautions:
Use aseptic technique. Initial transient rise in gonadotropins and sex steroids may result in increased signs/symptoms of puberty. Monitor for pseudotumor cerebri or psychiatric symptoms. History of seizures/epilepsy, cerebrovascular disorders, CNS anomalies or tumors: risk of convulsions. Monitor LH, FSH, and estradiol or testosterone at 1 month post implantation, then every 6 months thereafter. Assess height and bone age every 6–12 months. Nursing mothers.
SUPPRELIN LA Classification:
SUPPRELIN LA Interactions:
May interfere with pituitary gonadotropic and gonadal function tests. Caution with concomitant drugs that are associated with convulsions (eg, bupropion, SSRIs).
Implant site reactions (eg, discomfort, bruising, pain, soreness, erythema, swelling).
Generic Drug Availability:
Kit—1 (w. implant and insertion tool)